News

Zacks Investment Research on MSN2h
CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?
We expect investors to focus on the sales numbers of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other ...
Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies ...
Zacks Investment Research on MSN4h
CytomX Gears Up to Report Q1 Earnings: Here's What to Expect
CytomX Therapeutics CTMX, a clinical-stage oncology company, is expected to beat first-quarter 2025 earnings when it reports ...
Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?
Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.
SS Innovations International to list on US exchange Nasdaq
SS Innovations International, an Indian surgical robotics company, is set to list on the Nasdaq under the ticker 'SSII' on ...